Real-world Impact of Age at Diagnosis on Treatment Patterns and Survival Outcomes of Patients with Metastatic Pancreatic Ductal Adenocarcinoma

BACKGROUND: Sixty-eight percent of patients with pancreatic ductal adenocarcinoma (PDAC) are 65 years and older. Older adults are under-represented in clinical trials and their care is complicated with multiple age-related conditions. Research suggests that older patients can experience meaningful r...

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Rawad, Cockrum, Paul, Surinach, Andy, Wang, Shu, Chul Chu, Bong, Shahrokni, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Geriatric Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177118/
https://www.ncbi.nlm.nih.gov/pubmed/35278079
http://dx.doi.org/10.1093/oncolo/oyac028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177118/
https://www.ncbi.nlm.nih.gov/pubmed/35278079
http://dx.doi.org/10.1093/oncolo/oyac028

Ejemplares similares